For complete details on FDA status and approval timeline, see our guide: Is Retatrutide FDA Approved
The FDA does not review the safety and efficacy of compounded products, which are custom-made alternatives to brand drugs designed to meet a specific patients needs
$1,110$1,120 : Near the 52-week high around $1,112 and just above classic pivot resistance (R1R2 cluster)
Retatrutide weight loss data Retatrutide has produced the largest weight loss numbers ever recorded in a clinical trial for an anti-obesity medication
The Tapering Strategy : Avoid cold turkey cessation
Retatrutide is a triple receptor agonist (GLP-1, GIP, and glucagon) that suppresses appetite, improves insulin sensitivity, and promotes overall weight loss averaging 24.2% over 48 weeks in clinical trials